Eli Lilly and Co
-
Health News
Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024
[ad_1] Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual…
Read More » -
Health News
Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024
[ad_1] For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring…
Read More » -
Pics News
10-year Treasury yield falls slightly on shorter trading day
[ad_1] The 10-year U.S. Treasury yield fell marginally Friday as investors readied for a shorter trading day ahead of the holidays.…
Read More » -
Pics News
10-year Treasury yield falls as investors continue to assess path ahead for rate cuts
[ad_1] Thursday will see new data releases on gross domestic product growth and jobless claims. A rally in government debt…
Read More » -
Health News
Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma
[ad_1] Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts…
Read More » -
Pics News
Treasury yields dip slightly as Fed trajectory remains in focus
[ad_1] The yield on the benchmark 10-year Treasury note was down around 3.6 basis points to 3.8864%, having fallen below…
Read More » -
Health News
Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips
[ad_1] Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC…
Read More » -
Pics News
Treasury yields down slightly as recent trend continues
[ad_1] The 10-year U.S. Treasury yield retreated slightly on Tuesday, reversing course from the previous day’s trade and continuing a…
Read More » -
Business
The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead
[ad_1] George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024…
Read More » -
Health News
Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
[ad_1] The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the…
Read More »